Navigation Links
Cardiome And Astellas Announce Positive Results From ACT 2 Trial

icensing arrangements and their timing. Specifically, certain risks and uncertainties that could cause such actual events or results expressed or implied by such forward-looking statements and information to differ materially from any future events or results expressed or implied by such statements and information include, but are not limited to, the risks and uncertainties that: we may not be able to successfully develop and obtain regulatory approval for vernakalant (iv) or vernakalant (oral) in the treatment of atrial fibrillation or any other current or future products in our targeted indications; our future operating results are uncertain and likely to fluctuate; we may not be able to raise additional capital; we may not be successful in establishing additional corporate collaborations or licensing arrangements; we may not be able to establish marketing and sales capabilities and the costs of launching our products may be greater than anticipated; we rely on third parties for the continued supply and manufacture of vernakalant (iv) and vernakalant (oral) and we have no experience in commercial manufacturing; we may face unknown risks related to intellectual property matters; we face increased competition from pharmaceutical and biotechnology companies; and other factors as described in detail in our filings with the Securities and Exchange Commission available at www.sec.gov and the Canadian securities regulatory authorities at www.sedar.com. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements and information, which are qualified in their entirety by this cautionary statement. All forward-looking statements and information made herein are based on our current expectations and we undertake no obligation to revise or update such forward-looking statements and information to reflect subsequent eve
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cardiome And Astellas Announce Positive Results From ACT Trial
(Date:10/30/2014)... , Oct. 30, 2014  Misonix, Inc. (NASDAQ: ... company that designs, manufactures and markets innovative therapeutic ultrasonic ... announced today that it will report financial results for ... 6, 2014. The Company has scheduled a conference call ... pm ET to review the results. ...
(Date:10/30/2014)... , Oct. 30, 2014  Zimmer Holdings, Inc. (NYSE: ... the future executive leadership team and organizational structure of ... transaction.  Zimmer also announced that the combined organization will ... be named Zimmer Biomet, with the new brand to ... closing of the merger.  The future leadership team is ...
(Date:10/30/2014)...  The number of retail health clinics in ... thanks to drug store chains, according to Kalorama Information.  ... downturn, retail clinic growth had been at a standstill, ... number of retail clinics reached nearly 1,600 according to ... Overview and 2014 Consumer Survey Results .  ...
Breaking Medicine Technology:Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 3Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 4Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 5Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 6Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 7Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 8Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 9Report: Drugstore Chains Drive Retail Clinic Growth 2Report: Drugstore Chains Drive Retail Clinic Growth 3
... Oct. 26 Gentiva Health Services, Inc. (Nasdaq: GTIV ... services, announced today that it will present at the Oppenheimer ... ET on Tuesday, November 2, 2010 and the Credit Suisse ... (3:30 p.m. ET) on Wednesday, November 10, 2010. ...
... RICHMOND, Va., Oct. 26 Insmed Inc. (Nasdaq: ... it will host a conference call on Wednesday, November ... results for the third quarter 2010.  Insmed intends to ... market opens on November 3rd. To participate ...
Cached Medicine Technology:Gentiva® Health Services to Present at the Oppenheimer and Credit Suisse Healthcare Conferences 2Gentiva® Health Services to Present at the Oppenheimer and Credit Suisse Healthcare Conferences 3Insmed to Host Third Quarter 2010 Conference Call 2
(Date:10/30/2014)... Dr. Joseph Furlin MD, a certified obstetrician and gynecologist, has ... GYN in Melrose Park, IL and OB GYN ... about each of the care services and practice areas that ... and Spanish. The navigation of the website is easy ... Dr. Furlin’s patients with important information regarding his care methods ...
(Date:10/30/2014)... 2014 USARAD Holdings Inc ... and specialty telemedicine solutions provider, including SecondOpinions.com ... existing teleradiology services at Mission Bend ER, it ... telemedicine services, to the state-of-the-art, 24/7, freestanding ER ... of this innovative partnership, there will be many ...
(Date:10/30/2014)... York (PRWEB) October 30, 2014 The ... (NAMS) came to a close on Saturday, October ... since the Society’s inception in 1989. NAMS is North ... and quality of life of all women during midlife ... aging. With over 2,000 physicians and thought leaders from ...
(Date:10/30/2014)... WEDNESDAY, Oct. 29, 2014 (HealthDay News) -- When it comes ... likely than men to delay care when they have symptoms ... someone comes to the hospital with a more severe or ... options available," study author Catherine Kreatsoulas, a Fulbright Scholar and ... in a news release from the Heart and Stroke Foundation ...
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. ... be bad for your health, a new study reports. ... help strengthen bones and prevent osteoporosis. These benefits to bone ... part of a healthy diet. But this new study ... men or women from bone fractures, and was linked to ...
Breaking Medicine News(10 mins):Health News:Dr. Joseph Furlin Launches New Website with Information about Care Services 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3
... State University) and colleagues uncover a stem-cell specific role ... the developing mammalian embryo. ,Researchers had ... embryos. Using a combination of sophisticated mouse genetics and ... Rb is required for the maintenance of the trophoblast ...
... the the journal SLEEP, sleep-disturbed children are more severely ... disorders compared with children without sleep disturbance. ... sleep-disturbed children are advised to first consult with the ... sleep specialist for comprehensive testing and treatment. ...
... Scientists at the National Institute of Arthritis and Musculoskeletal ... of Health in Bethesda, Md., and colleagues at the ... in unprecedented detail, the virus that causes influenza. ... Steven, Ph.D., working with a version of the seasonal ...
... implicated in the onset of human puberty also ... rodents, report Indiana University Bloomington and// University of ... Endocrinology. The paper is now accessible online via ... ,The researchers present evidence that kisspeptin, a recently ...
... gene prevents the production of a critical blood-clotting protein. ... they exist//, may consist of risky blood transfusions or ... could be induced to begin producing these proteins, say ... lacking? ,Prof. Yair Reisner and Ph.D. student Anna ...
... and their collaborators are gaining widespread attention for discoveries ... babies to AIDS patients. ,Their findings about ... major scientific journals. Nature published a paper in its ... often you get such a cluster of papers coming ...
Cached Medicine News:Health News:Link Between Insomnia and Hypersomnia, Depression in Children 2Health News:Molecular Anatomy of Influenza Virus Detailed 2Health News:Sex Ends as Seasons Shift and Kisspeptin Levels Plummet 2Health News:Sex Ends as Seasons Shift and Kisspeptin Levels Plummet 3Health News:A Transplant in Time - Scientists ID Window for Tissue Transplant 2Health News:Findings on Dangerous Parasite, Toxoplasma Gondii Published 2
... The CALBIOTECH INC. (CBI) Prolactin ELISA ... of prolactin in human serum or plasma. ... chain polypeptide hormone with a molecular weight ... is based on a solid phase direct ...
... hormone secreted in significant amounts by the ... in synergy with estrogen, plays an important ... of mammary gland growth and lactation in ... effects on cell growth in other tissues ...
... ADVIA Centaur delivers a new ... provides the flexibility to integrate ... now and in the future. ... comprehensive disease-focused menu of immunoassays ...
... The Anti-MPO - ELISA (P-ANCA) ... MPO antibodies using highly purified myeloperoxidase ... by contaminations like lactoferrin or elastase ... can not be detected by indirect ...
Medicine Products: